Your browser doesn't support javascript.
loading
Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3.
Zhang, Wei; Fan, Zhixing; Wang, Fengyuan; Yin, Lin; Wu, Jinchun; Li, Dengke; Song, Siwei; Wang, Xi; Tang, Yanhong; Huang, Congxin.
Afiliación
  • Zhang W; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Fan Z; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.
  • Wang F; Hubei Key Laboratory of Cardiology, Wuhan 430060, China.
  • Yin L; Department of Cardiology, The First College of Clinical Medical Sciences, China Three Gorges University & Yichang Central People's Hospital, Yichang, 443000 Hubei Province, China.
  • Wu J; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Li D; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.
  • Song S; Hubei Key Laboratory of Cardiology, Wuhan 430060, China.
  • Wang X; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Tang Y; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.
  • Huang C; Hubei Key Laboratory of Cardiology, Wuhan 430060, China.
Oxid Med Cell Longev ; 2023: 9966355, 2023.
Article en En | MEDLINE | ID: mdl-36691640
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sirtuina 3 / Lesiones Cardíacas Límite: Animals Idioma: En Revista: Oxid Med Cell Longev Asunto de la revista: METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sirtuina 3 / Lesiones Cardíacas Límite: Animals Idioma: En Revista: Oxid Med Cell Longev Asunto de la revista: METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: China